These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
572 related articles for article (PubMed ID: 16418885)
1. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma. Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885 [TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004. Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331 [TBL] [Abstract][Full Text] [Related]
4. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database. Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103 [TBL] [Abstract][Full Text] [Related]
5. Results of sentinel lymph node biopsy in patients with thin melanoma. Wong SL; Brady MS; Busam KJ; Coit DG Ann Surg Oncol; 2006 Mar; 13(3):302-9. PubMed ID: 16485151 [TBL] [Abstract][Full Text] [Related]
6. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma. Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039 [TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421 [TBL] [Abstract][Full Text] [Related]
8. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Kesmodel SB; Karakousis GC; Botbyl JD; Canter RJ; Lewis RT; Wahl PM; Terhune KP; Alavi A; Elder DE; Ming ME; Guerry D; Gimotty PA; Fraker DL; Czerniecki BJ; Spitz FR Ann Surg Oncol; 2005 Jun; 12(6):449-58. PubMed ID: 15864482 [TBL] [Abstract][Full Text] [Related]
9. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531 [TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node status in melanoma: a valuable prognostic factor? Topar G; Eisendle K; Zelger B; Fritsch P Br J Dermatol; 2006 Jun; 154(6):1080-7. PubMed ID: 16704637 [TBL] [Abstract][Full Text] [Related]
11. A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system. Wong SL; Kattan MW; McMasters KM; Coit DG Ann Surg Oncol; 2005 Apr; 12(4):282-8. PubMed ID: 15827679 [TBL] [Abstract][Full Text] [Related]
12. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755 [TBL] [Abstract][Full Text] [Related]
13. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma. Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939 [TBL] [Abstract][Full Text] [Related]
14. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306 [TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608 [TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957 [TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary? Nahabedian MY; Tufaro AP; Manson PN Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009 [TBL] [Abstract][Full Text] [Related]
18. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Gajdos C; Griffith KA; Wong SL; Johnson TM; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS Cancer; 2009 Dec; 115(24):5752-60. PubMed ID: 19827151 [TBL] [Abstract][Full Text] [Related]
19. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442 [TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy in patients with thin melanoma: occurrence of nodal metastases and its prognostic value. Vermeeren L; Van der Ent F; Sastrowijoto P; Hulsewé K Eur J Dermatol; 2010; 20(1):30-4. PubMed ID: 19889594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]